Translational Development Acquisition market cap TDAC
Share price times shares outstanding: what the whole company sells for, since 2025.
- Today, Nov 2, 2026
- $209.1M
- Highest close in our data
- $237.9M
- Aug 2026
Translational Development Acquisition is worth $209.1M at the close on Nov 2, 2026, at $10.83 a share.
That is down 9% over the last year.
Its highest close in our data was $237.9M in Aug 2026.
Market cap over time
Year by year
| Year | End of year | Low | High | Change |
|---|---|---|---|---|
| 2026 so far | $209.1M | $208.7M | $237.9M | −9% |
| 2025 | $229.2M | $221M | $229.2M | n/a |
Against its peers
Companies in Financial Services nearest Translational Development Acquisition's size, closest first, today.
| Company | Market cap |
|---|---|
| TDACTranslational Development Acquisition | $209.1M |
| DHXDHI | $207.6M |
| CBFVCB Financial Services | $203.8M |
| FCAPFirst Capital | $214.6M |
| RBKBRhinebeck Bancorp | $202.3M |
| CPSSConsumer Portfolio Services | $218.7M |
| MRBKMeridian | $221.5M |
| LARKLandmark Bancorp | $197.4M |
| GBFHGBank Financial | $222.4M |
| SBFGSB Financial | $196.5M |
| FNWDFinward Bancorp | $192.5M |
| Peer median | $205.7M |
What the market cap tells you
Share price times shares outstanding: what the whole company sells for today.
Size, not quality. Large caps move slower and are covered more. That is all it tells you.
More on Translational Development Acquisition
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.